Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenxbio (RGNX) Equity Ratio (2016 - 2025)

Regenxbio (RGNX) has 12 years of Equity Ratio data on record, last reported at 0.23 in Q4 2025.

  • For Q4 2025, Equity Ratio fell 59.3% year-over-year to 0.23; the TTM value through Dec 2025 reached 0.23, down 59.3%, while the annual FY2025 figure was 0.23, 59.3% down from the prior year.
  • Equity Ratio reached 0.23 in Q4 2025 per RGNX's latest filing, down from 0.31 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.69 in Q4 2021 and bottomed at 0.23 in Q4 2025.
  • Average Equity Ratio over 5 years is 0.56, with a median of 0.6 recorded in 2021.
  • Peak YoY movement for Equity Ratio: increased 28.63% in 2021, then crashed 59.3% in 2025.
  • A 5-year view of Equity Ratio shows it stood at 0.69 in 2021, then decreased by 9.72% to 0.62 in 2022, then fell by 12.32% to 0.54 in 2023, then grew by 2.59% to 0.56 in 2024, then plummeted by 59.3% to 0.23 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.23 in Q4 2025, 0.31 in Q3 2025, and 0.37 in Q2 2025.